Vireo Ag
Vireo Ag develops next-generation plant genome editing tools that enable single-generation, transgene-free, tissue-culture-free editing directly in elite crop varieties. Our platform reduces crop development timelines and costs by over 70%, allowing seed companies, trait developers, and select CPG partners to integrate genome editing seamlessly into existing breeding pipelines. Vireo operates as a capital-light platform technology provider, licensing tools across multiple crops to accelerate innovation without disrupting downstream seed or trait commercialization.